Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
Operating Margin history
Percent of revenue · from the income statement
No Operating Margin data reported for this period type.
Operating Margin vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 20.7% | +9.2 pp | +150.6 pp | |
| LTM Mar 2026 | 17.6% | +107.2 pp | +1139.8 pp | |
| LTM Sep 2026 | -276.5% | — | — | |
| LTM Mar 2026 | -961.9% | -168.3 pp | -673.9 pp | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | -6204.4% | -4015.0 pp | — |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — |
ORKAOruka Therapeutics, Inc. | FY2025 | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | FY2024 | — | — | — |
| FY2025 | — | — | — | |
| Peer median (excluding ODTX) | -276.5% | -79.5 pp | +150.6 pp | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.